Aspire Biopharma Holdings ASBP Income Statement (2021-2026)

NASDAQ ASBP
$8.15 +0.33 (+4.31%)
As of: Aug 21, 2026 · 2:38 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.00M0.00M0.03M0.06M
Cost of Revenue (Quarter)
0.00M0.01M0.02M0.05M
Gross Profit (Quarter)
884.00-0.00M0.01M-0.03M
Operating items
Research & Development (Quarter)
0.09M0.01M0.01M0.10M0.26M0.05M0.21M0.09M0.33M1.22M
Selling, General & Administrative (Quarter)
0.02M755.000.11M0.30M0.26M0.31M0.32M0.29M0.32M0.40M0.13M0.09M0.19M0.53M15.07M0.40M0.51M1.66M1.02M0.97M
Restructuring Costs (Quarter)
0.09M0.40M0.23M
Other Operating Expenses (Quarter)
0.01M-0.09M0.02M0.04M0.22M-0.04M0.43M0.10M0.30M0.23M
Operating Expenses (Quarter)
0.02M755.000.11M0.30M0.26M0.31M0.32M0.29M0.32M0.40M0.23M0.10M0.22M0.67M15.56M0.80M1.15M1.85M1.65M2.65M
Operating Income (Quarter)
-0.22M-0.67M-15.56M-1.15M-1.85M-1.65M-2.68M
EBIT (Quarter)
-0.22M-0.67M-15.56M-1.15M-1.85M-1.65M-2.68M
Non-operating items
Interest & Investment Income (Quarter)
0.02M0.42M1.33M2.54M3.20M2.10M0.26M0.26M0.23M0.17M
Other Non Operating Income (Quarter)
-0.09M-0.29M0.78M1.17M0.25M1.35M
Non Operating Income (Quarter)
0.02M0.42M1.33M2.54M3.20M2.10M0.26M0.25M0.06M-0.10M-0.38M-1.18M-0.70M-2.86M-1.58M1.41M
Net income details
EBT (Quarter)
-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M-1.27M
Tax Provisions (Quarter)
0.00M
Profit After Tax (Quarter)
-0.02M-755.00-0.09M0.12M1.08M2.23M2.87M1.81M-0.07M-0.15M-0.23M-0.10M-0.22M-0.77M-15.94M-1.98M-1.85M-4.71M-3.22M-1.27M
Income from Continuing Operations (Quarter)
-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M-1.27M
Consolidated Net Income (Quarter)
-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M-1.27M
Income towards Parent Company (Quarter)
-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M-1.27M
Net Income towards Common Stockholders (Quarter)
-0.02M-755.00-0.04M0.02M0.86M-0.09M0.57M1.47M-0.07M-0.11M-2.47M-0.60M-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M-1.27M
Additional items
EPS (Basic) (Quarter)
-2.94-0.14-4.381.0135.97-4.3423.98110.76-9.24-7.95-329.25-85.37-33.42-1.41-504.87-63.62-162.20-20.57-1.22
EPS (Diluted) (Quarter)
-2.94-0.14-4.381.0135.97-4.3423.98110.76-9.24-7.95-329.25-85.37-33.42-1.41-504.87-63.62-162.20-20.57-1.22
Shares Outstanding (Quarter)
0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.42M0.03M0.04M0.04M0.05M0.16M1.04M
Shares Outstanding (Diluted) (Quarter)
0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.42M0.03M0.04M0.04M0.05M0.16M1.04M
Shares Outstanding (Entity) (Quarter)
0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.42M0.03M0.04M0.04M0.05M0.17M7.51M
EBITDA (Quarter)
-0.22M-0.67M-15.56M-1.15M-1.85M-1.65M-2.68M
Interest Expenses (Quarter)
0.18M0.12M-0.07M0.29M0.53M1.48M6.23M1.60M0.07M
Tax Rate (Quarter)
-0.47%